The Llr Tap Iciclle Trial Assessing Biological Response to Ibrutinib in Cll: Immediate Disease Redistribution Precedes Cell Cycle Arrest by 2 Weeks with Reduced Bone Marrow Infiltration by 6 Months
Authors
Rawstron, AMunir, T
Dalal, S
Thompson, J
Yap, C
Brock, K
Yates, F
Ogburn, E
Fox, C
MacDonald, D
Fegan, C
Bloor, Adrian
Hillmen, P
Affiliation
St. James’s Institute of Oncology, LeedsIssue Date
2015